(Bloomberg) – US evidence for monkeypox is insufficient to determine the distribution of the virus and where new cases are emerging, according to infectious disease experts and advocates concerned about a slow response to the outbreak that has already affected 32 countries.
Although government labs have the capacity to test up to 8,000 samples a week, they only use 2% of that capacity, suggesting that about 23 smallpox tests are being performed a day, James said. Krellenstein, co-founder of PrEP4All, an HIV virus. defense group that expanded its focus during the pandemic. Many more tests are needed to find out where the pathogen is and how fast it moves, he said.
It is commonly seen in African countries where most human cases are caused by shedding of infected animals, the smallpox of the monkey has spread through close contact, mainly between men who have sex with men. Although it does not move as fast as Covid-19, more than 1,600 cases have been reported worldwide since health officials began tracking them last month, including 72 in the U.S. through Tuesday. The situation echoes the early days of Covid-19, when defective tests by the Centers for Disease Control and Prevention allowed the pandemic to spread undetected in the United States, Krellenstein said.
“It’s worrying that the CDC isn’t pushing for that, especially after Covid,” he said in an interview. “This is a critical period: outbreaks become more difficult to control as time goes on.”
How many viruses?
Monkeypox is diagnosed in designated public health laboratories with a type of molecular test approved by the Food and Drug Administration, called PCR, that recognizes viral genetic material. Currently, all testing is done through the government’s network of labs, which experts say is cumbersome, leading to possible delays in identifying new cases and the risk of losing wider community outreach.
Evidence is so limited that it is impossible to know how much of the virus circulating in the United States is being caught, said Ranu Dhillon, an infectious disease physician at Harvard Medical School and Brigham and Women’s Hospital in Boston. It could be 90% or just 10%, he said.
“This challenge of expanding and decentralizing testing in response to an outbreak with widespread and unknown transmission chains is not new,” Dhillon said. “It has been a common theme in several recent outbreaks,” including Ebola, Zika virus and, of course, Covid.
Experts urged decentralization of testing and support for expansion into laboratories and hospitals capable of performing PCR testing, especially in places like sexual health clinics where many monkeypox patients appear.
“We absolutely need to ensure that all hospitals with a laboratory, a molecular virology lab, can test their patients for monkeypox,” said Michael Mina, a former Harvard epidemiologist who is now the scientific director of eMed. ven. Covid tests at home.
Raj Panjabi, the White House’s senior director of global health security and biodefense, said on Friday that more than 300 PCR tests had been performed for the monkey’s smallpox and there had been a 45% increase weekly. The CDC said 556 copies had been tested as of Monday.
U.S. health officials say they are working to extend the tests to companies and other government labs. The CDC has published online instructions for making primers (DNA sequences used in PCR tests) so that labs can begin creating their own monkeypox assays.
Phase expansion
“We’ve posted a guide on our website with our trial information that anyone could replicate if they wanted to develop their own test,” said Jennifer McQuiston, deputy director of the CDC’s Division of Pathogens and High-Consequence Pathology. “We also know that some people want to take the CDC test and install it in a commercial lab, and we’re looking at ways to help them do that.”
On Friday, the Association of Public Health Laboratories said that if the outbreak continues to grow, it supports a “gradual expansion” of monkeypox testing in the U.S. The FDA says it is preparing to make a molecular emergency use authorization template available in case the outbreak is declared a public health emergency.
Medical technology company Becton Dickinson and Co. and Zaragoza-based CerTest Biotec said they are teaming up to develop a PCR assay for monkeypox. Swiss pharmaceutical giant Roche Holding AG said it has already developed three different smallpox tests, while Abbott Laboratories said in late May it was working on a test.
Test giant Labcorp said it is “evaluating all available options to support increased monkeypox testing,” including partnerships with the CDC, other government agencies, and groups such as the American Laboratory Association. Clinics. Quest Diagnostics Inc. he said he is not offering a smallpox test, but is exploring options.
Bottlenecks in the system could become a bigger problem as the outbreak expands. High demand could lead to delays in test response time in public health labs, said Bryon Backenson, director of communicable diseases at the New York State Department of Health. A Washington-based doctor told Twitter it took him six hours to get a call from his public health lab about a suspected case of monkeypox.
“One thing we’ve learned from Covid is that the availability of evidence is very important,” Backenson said. “Having more labs and more people capable of testing is a good thing.”
U.S. health agencies began planning a smallpox outbreak after the September 11, 2001 attacks and mail-sent anthrax spores raised concerns about bioterrorism. This has helped strengthen the health system against emerging diseases such as monkeypox, but there are still significant gaps that appeared in the early days of the pandemic.
Covid’s early control efforts were affected by faulty test kits and the centralized U.S. approach, along with regulatory hurdles. CDC tests may have lost one of the first infections in the United States, which has led to additional exposure to the community, experts say. Few tests were being performed in February or March 2020, although the virus was already spreading in the United States at the time.
Other practices may limit the recognition of monkeypox spread. Most tests are currently reserved for people with a characteristic rash who are men who have sex with men or who have recently traveled abroad, according to Paul Sax, an infectious disease physician at Harvard and Brigham and Women’s. Hospital. Most people tested by the New York Department of Health have been men, Backenson said. Some people told PrEP4All that their own doctors had rejected them for smallpox testing, Krellenstein said.
Smallpox can also be confused with some sexually transmitted infections, such as herpes or syphilis, health officials said. Backenson said some New York patients who may have had monkeypox were not tested because they were positive for other pathogens. The CDC warned doctors this week that patients with rashes typically characteristic of other infections should be carefully evaluated for monkeypox and that co-infections are possible.
Restrictive testing could create blind spots as the virus spreads to other populations. Focusing on men could lead to lost infections in women or children, Dhillon of Harvard said. The United States should do excessive testing for monkeypox to ensure that the full extent of the outbreak is known, he said.
© 2022 Bloomberg LP